BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 30203110)

  • 21. Palliative interstitial HDR brachytherapy for recurrent rectal cancer. Implantation techniques and results.
    Kolotas C; Röddiger S; Strassmann G; Martin T; Tselis N; Aebersold DM; Baltas D; Zamboglou N
    Strahlenther Onkol; 2003 Jul; 179(7):458-63. PubMed ID: 12835882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reirradiation for patients with recurrence head and neck squamous cell carcinoma: a single-institution comparative study.
    Rudžianskas V; Inčiūra A; Vaitkus S; Padervinskis E; Rudžianskienė M; Kupčinskaitė-Noreikienė R; Saltonaitė L; Noreika A; Statnickaitė A; Juozaitytė E
    Medicina (Kaunas); 2014; 50(2):92-9. PubMed ID: 25172603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer.
    Tselis N; Ratka M; Vogt HG; Kolotas C; Baghi M; Baltas D; Fountzilas G; Georgoulias V; Ackermann H; Zamboglou N
    Radiother Oncol; 2011 Jan; 98(1):57-62. PubMed ID: 21129799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
    Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.
    Miwa K; Matsuo M; Ogawa S; Shinoda J; Yokoyama K; Yamada J; Yano H; Iwama T
    Radiat Oncol; 2014 Aug; 9():181. PubMed ID: 25123357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-irradiation with radiosurgery for recurrent glioblastoma multiforme.
    Torok JA; Wegner RE; Mintz AH; Heron DE; Burton SA
    Technol Cancer Res Treat; 2011 Jun; 10(3):253-8. PubMed ID: 21517131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inversely and adaptively planned interstitial brachytherapy: A single implant approach.
    Hanania AN; Myers P; Yoder AK; Bulut A; Henry Yu Z; Eraj S; Bowers J; Bonnen MD; Echeverria A; Hall TR; Anderson ML; Ludwig M
    Gynecol Oncol; 2019 Feb; 152(2):353-360. PubMed ID: 30449720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
    Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
    Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
    Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
    Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.
    Umezawa R; Murakami N; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Takahashi K; Inaba K; Ito Y; Igaki H; Masui K; Yoshida K; Jingu K; Tselis N; Itami J
    Brachytherapy; 2018; 17(2):368-376. PubMed ID: 29275869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Image-guided vulvovaginal interstitial brachytherapy in the treatment of primary and recurrent gynecological malignancies.
    De Ieso PB; Mullassery V; Shrimali R; Lowe G; Bryant L; Hoskin PJ
    Brachytherapy; 2012; 11(4):306-10. PubMed ID: 21996537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Iridium 192 brachytherapy of supra-tentorial high grade glioma recurring in irradiated areas: technique and preliminary results of the Pitié-Salpêtrière hospital group].
    Boisserie G; Cornu P; Dormont D; Sahel M; Hardiman C; Tep B; Mandin AM; Barret C; Faillot T; Delattre JY; Monjour A; Poisson M; Marsault C; Philippon J; Simon JM; Baillet F; Mazeron JJ
    Bull Cancer Radiother; 1996; 83(3):144-52. PubMed ID: 8977564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
    Gebhardt BJ; Vargo JA; Kim H; Houser CJ; Glaser SM; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Courtney-Brooks M; Beriwal S
    Gynecol Oncol; 2018 Aug; 150(2):293-299. PubMed ID: 29929925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume.
    Simon JM; Cornu P; Boisserie G; Hasboun D; Tep B; Hardiman C; Valery CA; Delattre JY; Dormont D; Baillet F; Mazeron JJ
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):67-74. PubMed ID: 12007943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer.
    Strouthos I; Chatzikonstantinou G; Zamboglou N; Milickovic N; Papaioannou S; Bon D; Zamboglou C; Rödel C; Baltas D; Tselis N
    Radiother Oncol; 2018 Aug; 128(2):301-307. PubMed ID: 29764692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy?
    Koot RW; Habraken JB; Hulshof MC; Paans AM; Bosch DA; Pruim J
    Acta Neurochir (Wien); 2008 Apr; 150(4):345-9. PubMed ID: 18278573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas.
    Zamorano L; Li Q; Tekyi-Mensah S; Gaspar L; Fontanesi J; Levin K
    Stereotact Funct Neurosurg; 2003; 81(1-4):10-7. PubMed ID: 14742958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.